$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

울주군에서 발생한 장출혈성대장균 감염증의 발생 원인
Cause of Enterohemorrhagic Escherichia coli Infection in Ulju County, Korea 원문보기

예방의학회지 = Korean journal of preventive medicine, v.36 no.1, 2003년, pp.77 - 84  

이상원 (국립보건원 전염병관리부 역학조사과) ,  양병국 (국립보건원 전염병관리부 역학조사과) ,  이복권 (국립보건원 세균부 장내세균과) ,  박재구 (국립보건원 세균부 장내세균과) ,  황병훈 (울주군보건소) ,  임현술 (동국대학교 의과대학 예방의학교실) ,  배근량 (국립보건원 전염병관리부 역학조사과)

Abstract AI-Helper 아이콘AI-Helper

Objectives : Two related cases of Hemolytic-Uremic Syndrome (HUS) were reported to the Korea National Institute of Health in May, 2001. Shiga toxin 2 genes were detected in both stool samples. We suspected an enterohemorrhagic Escherichia coli (EHEC) infection as the cause of the HUS, and conducted ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 본 조사는 용혈성요독증후군의 원인이 장출혈성대장균 감염에 의한 것인지를 확인하고 그 발병의 규모 및 발병원인과 전파경로를 파악하여 예방대책을 수립하 고자 수행호였다.
본문요약 정보가 도움이 되었나요?

참고문헌 (44)

  1. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA. Illnesses associated with Escherichia coli 0157:H7 infections. A broad clinical spectrum. Ann Intern Med 1988; 109(9): 705-712 

  2. Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet 1998; 352: 1207-1212 

  3. KNIH. Infection of enterohemorrhagic Escherichia coli. CDMR 2001; 12(9): 97103 (Korean) 

  4. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607-625 

  5. Fukushima H, Hashizume T, Morita Y, Tanaka J, Azuma K, Mizumoto Y, Kaneno M, Matsuura M, Konma K, Kitani T. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli 0157 infections in Sakai City, 1996. Pediatr Int 1999; 41(2): 213-217 

  6. 국립보건원. 장출혈성대장균 감염증 역학조사지침. 200I. p. 12-14 

  7. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli 0157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13: 60-98 

  8. Chin J Ascher MS. Control of Communicable Diseases Manual. 17th ed. Washington: American Public Health Association; 2000. p. 154-158. 

  9. Swerdlow DL, Woodruff BA, Brady RC, Griffin PM, Tippen S, Donnell HD, Geldreich E,Payne BJ, Meyer A, Wells JG. A waterborne outbreak in Missouri of Escherichia coli 0157:H7 associated with bloody diarrhea and death. Ann Int Med 1992; 117(10): 812-819 

  10. Brewster DH, Brown MI, Robertson D, Houghton GL, Bimson J, Sharp JC. An outbreak of Escherichia coli 0157 associated with a children' s paddling pool. Epidemiollnfect 1994; 112(3): 441-447 

  11. Keene WE, McAnulty JM, Hoesly FC, Williams LP, Hedberg K, Oxman GL, Barrett rr, Pfaller MA, Fleming OW. A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli 0157:H7 and Shigella sonnei. N Engl J Med 1994; 331(9): 579-584 

  12. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli OI57:H7 infection in Minnesota child day-care facilities. JAMA 1993; 269(7): 883-888 

  13. CDC. Outbreaks of Escherichia coli O157:H7 Infections Among Children Associated With Farm Visits - Pennsylvania and Washington, 2000. MMWR 2001;50(15):293-297 

  14. Beutin L, Bulte M, Weber A, Zimmermann S, Gleier K. Investigation of human infections with verocytotoxin-producing strains of Escherichia coli (VTEC) belonging to serogroup 0118 with evidence for zoonotic transmission. Epidemiol Infect 2000; 125(1): 47-54 

  15. Tarr PI. Escherichia coli 0157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 1995; 20: 1-10 

  16. Bokete TN, O'Callahan CM, Clausen CR, Tang NM, Tran N, Moseley SL, Fritsche TR, Tarr PI. Shiga-like toxin-producing Escherichia coli in Seattle children: a prospective study. Gastroenterology 1993; 105: 1724-1731 

  17. Park CH, Gates KM, Vandel NM, Hixon DL. Isolation of Shiga-like toxin producing Escherichia coli (0157 and non-0157) in a community hospital. Diagn Microbial Infect Dis 1996; 26: 69-72 

  18. Caprioli A, Tozzi AE, Rizzoni G, Karch H. Non-O 157 Shiga toxin-producing Escherichia coli infections in Europe. Emerg Infect Dis 1997; 3: 578-579 

  19. Talan D, Moran GJ, Newdow M, Ong S, Mower WR, Nakase JY, Pinner RW, Slutsker L. Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens. Clin Infect Dis 2001; 32(4): 573-580 

  20. Verweyen HM, Karch H, Allerberger F, Zimmerhackl, LB. Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic- uremic syndrome: a prospective study in Germany and Austria. Infection 1999; 27(6): 341-347 

  21. Montenegro MA, Bulte M, Trumpf T, Aleksic S, Reuter G, Bulling E, Helmuth R. Detection and characterization of fecal verotoxin-producing Escherichia coli from healthy cattle. J Clin Microbial 1990; 28(6): 1417-1421 

  22. CDC. Outbreak of acute gastroenteritis attributable to Escherichia coli serotype 0104:H21: Helena, Montana, 1994. MMWR 1995; 44: 501-503 

  23. Banatvala N, Debeukelaer MM, Griffin PM, Barrett TJ, Greene KD, Green JH, Wells JG. Shiga-like toxin-producing Escherichia coli 0 III and associated hemolytic uremic syndrome: a family outbreak. Pediatr Infect Dis J 1996; 15: 1008-1011 

  24. Huppertz HI, Busch D, Svchmidt H, Aleksic S, Karch H. Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shigatoxin. J Pediatr 1996; 128: 341-346 

  25. Keskimaki M, Saari M, Heiskanen T, Siitonen A. Shiga toxin-producing Escherichia coli in Finland from 1990 through 1997; prevalence and characteristics of isolates. J Clin Microbial 1998; 36: 3641-3646 

  26. Welinder-Olsson C, Kjellin E, Badenfors M, Kaijser B. Improved microbiological techniques using the polymerase chain reaction and pulsed-field gel electrophoresis for diagnosis and follow-up of enterohaemorrhagic Escherichia coli infection. Eur J Clin Microbial Infect Dis 2000; 19(11): 843-851 

  27. Beutin L, Geier D, Steinruck H, Zimmermann S, Scheutz F. Prevalence and some properties of verotoxin (Shiga-like toxin)- producing Escherichia coli in seven different species of healthy domestic animals. J Clin Microbial 1993; 31(9): 2483-2488 

  28. Zschock M, Hamann HP, Kloppert B, Wolter W. Shiga-toxin producing Escherichia coli in faeces of healthy dairy cows, sheep and goats: prevalence and virulence properties. Lett Appl Microbial 2000; 31(3): 203-208 

  29. Wells JG, Shipman LD, Greene KD, Sowers EG, Green JH, Cameron ON, Downes FP, Martin ML, Griffin PM, Ostroff SM. Isolation of Escherichia coli serotype 0157:H7 and other Shiga-liketoxin- producing E. coli from dairy cattle. J Clin Microbial 1991; 29(5): 985-989 

  30. Wilson lB, McEwen SA, Clarke RC,Leslie KE, Wilson RA, Waltner-Toews D, Gyles CL. Distribution and characteristics of verocytotoxigenic Escherichia coli isolated from Ontario dairy cattle. Epidemiollnfect 1992; 108(3): 423-439 

  31. Kobayashi H, Shimada J, Nakazawa M, Morozumi T, Pohjanvirta T, Pelkonen S, Yamamoto K. Prevalence and characteristics of shiga toxin-producing Escherichia coli from healthy cattle in Japan. Appl nviron Microbial 2001; 67(1): 484-489 

  32. Karmali MA. Infection by verocytotoxinproducing Escherichia coli. Clin Microbial Rev 1989; 2(1): 15-38 

  33. Louise CB, Obrig TG. Shiga toxin-asso ciated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 1992; 60: 1536-1543 

  34. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli 0157:H7 infections. N Engl J Med 2000; 342(26): 1930-1936 

  35. Ryan CA, Tauxe RV, Hosek GW, Wells JG, StoeszPA,McFadden HW,SmithPW, Wright GF, Blake PA. Escherichia coli 0157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings. J Infect Dis 1986; 154(4): 631-638 

  36. Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, Wells JG, Siegler RL, Brewer ED, Hannon D. Hemolytic-uremic syndrome during an outbreak of Escherichia coli 0157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 1990; 116(4): 544-551 

  37. Slutsker L, Ries AA, Maloney K, Wells JG, GreeneKD, Griffin PM. A nationwide case-control study of Escherichia coli 0157:H7 infection in the United States. J Infect Dis 1998; 177(4): 962-966 

  38. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli 0157:H7, other enterohemorrhagic E coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13:60-98 

  39. Griffin PM. Escherichia coli 0157:H7 and other enterohemorrhagic Escherichia coli. In: Blaser MJ, Smith PD, Rovin n, Greenberg HB, Guerrant RL, editors. Infections of the gastrointestinal tract. New York: Raven Press; 1995. p. 739-761 

  40. Heuvelink AE, van de Kar NC, Meis JF, Monnens LA, Melchers WJ. Characterization of verocytotoxin-producing Escherichia coli 0157 isolates from patients with haemolytic uraemic syndrome in Western Europe. EpidemiolInfect 1995; 115(1): 1-14 

  41. Louise CB, Obrig TG. Specific interaction of Escherichia coli 0157:H7-derived Shiga-like toxin II with human renal endothelial cells. Infect Dis 1995;172(5): 1397-1401 

  42. CDC. Summary of Notifiable Diseases United States, 2000.MMWR 2002; 49(53): 13 

  43. Banatvala N, Griffin PM, Greene KD, Barrett TJ. Bibb WF. Green JH. Wells JG. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 2001; 183: 1063-1070 

  44. Mead PS, Finelli L, Lambert-Fair MA, ChampD, TownesJ, Hutwagner L, Barrett T, Spitalny K Mintz E. Risk factors for sporadic infection with Escherichia coli OI57:H7. Arch Intern Med 1997; 157(2): 204-208 

저자의 다른 논문 :

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로